EVNIN LUKE sold 25.8% of their position (407.57K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $280.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/12/2026ACC: 0001134657-26-000010
Director10% Owner
Since Apr 2021
-407.57K
Net shares
Net seller
$280.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
407.57K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−305.74K
Price / share
$0.70
Trade value
$214.02K
% of position
19.4%
5/8/2026
1.58M→1.27M
Common Stock
Indirect
Shares
−33.95K
Price / share
$0.67
Trade value
$22.75K
% of position
2.7%
5/11/2026
1.27M→1.24M
Common Stock
Indirect
Shares
−67.89K
Price / share
$0.64
Trade value
$43.45K
% of position
5.5%
5/12/2026
1.24M→1.17M
Total
Net shares
−407.57K
Net value
-$280.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/8/2026 | S · Sale | −305.74K | $0.70 | $214.02K | 19.4% | 1.58M | 1.27M |
| Common Stock Indirect | 5/11/2026 | S · Sale | −33.95K | $0.67 | $22.75K | 2.7% | 1.27M | 1.24M |
| Common Stock Indirect | 5/12/2026 | S · Sale | −67.89K | $0.64 | $43.45K | 5.5% | 1.24M | 1.17M |
| Total | −407.57K | -$280.21K | ||||||
Derivative Transactions0
No derivative transactions reported